Canine Parvo Virus Antibody Rapid Test Parvovirus in Dogs Parvo Treatment

• Customization: Available
• Type: Detection Card
• Syringe: None
• Model NO.: JCA005D
• Blood Sampling Needle: None
• Breathing Pattern: None
• Animal Anesthesia Machine Control Method: None
• Box Size: 15cm*10cm*8cm
• Packing: 80 Box Per Carton
• Carton Size: 68cm*44cm*44cm
• Assay Time: 5-10 Minutes
• Delivery Time: 3~5days After Get Payment
• Transport Package: Carton
• Specification: 10 test per box
• Trademark: PETX
• Origin: China
• HS Code: 3822001000
• Production Capacity: 50000PCS/Mont

Product Description

• INTENDED USE
• The Canine Parvo Virus Antibody Rapid Test is a lateral flow immunochromatographic assay for the semi-quantitative detection of Canine Parvo Virus Antibody (CPV Ab) in dog's serum, or plasma.
  Assay Time:  10 minutes
  Specimen: serum, or plasma.
• PRINCIPLE
• The Canine Parvo Virus Antibody Rapid Test is based on sandwich lateral flow immunochromatographic assay.
• REAGENTS AND MATERIALS
• Test devices
• Disposable droppers
• Assay buffer (0.3mL each bottle, X10)
• Products Manual
• 
• STORAGE AND STABILITY
• The kit can be stored at room temperature (4-30°C). The test kit is stable through the expiration date (24 months) marked on the package label. DO NOT FREEZE. Do not store the test kit in direct sunlight.
• TEST PROCEDURE
• Allow all materials, including specimen and test device, recover to 15-25ºC before running the assay.
• Take out the test device from the foil pouch and place it horizontally.
• Place 3 drops (or 150μL) of serum specimen into one assay buffer bottle and mix them.
• Drop 3 drops of the diluted specimen into the sample hole "S" of the test device.
• Interpret the result in 10 minutes. Result after 15 minutes is considered as invalid.
• 
• INTERPRETATION OF RESULTS
• The presence of "C" line indicates a valid result. Read the result by comparing the color intensity of the "T" line with the standard color reference scale (from "G1" to "G6"). The H.I. titers of canine parvo virus antibodies are corresponding with the color intensity grades.

  G1 < 1:40	G2 = 1:40	G3 = 1:80
  G4 = 1:160	G5 = 1:320	G6 > 1:640

  Positive (+): The presence of both "C" line and zone "T" line. T line at G3 is considered as standard positive. T line < G3, is weak positive and indicates low CPV antibody level. T line around G4-G5, is strong positive. T line > G6, is very strong positive, indicates a contact with virus recently or in infection.
• Negative (-): Clear C line appears. No T line, or T line is weaker than G1. It indicates very low CPV titer. Failed immunization may happen.   
• Invalid: No colored line appears in C zone.
• PRECAUTIONS
• All reagents must be at room temperature before running the assay.
• Do not remove test cassette from its pouch until immediately before use.
• Do not use the test beyond its expiration date. 
• The components in this kit have been quality control tested as standard batch unit. Do not mix components from different lot numbers.
• All specimens are of potential infection. It must be strictly treated according to the rules and regulations by local states.
• LIMITATION
• Canine Parvo Virus Antibody Rapid Test is for in vitro veterinary diagnosis use only. All result should be considered with other clinical information available with veterinarian.
  
  J&G Biotech Ltd (Reg. No.: 08419172)
  326 Cleveland Road, London, England E18 2AN, UK
• 

Company Profile

Hangzhou Immuno Biotech Co., Ltd is the original organization in IMMNUO Group, which was established in 2014. The team of Hangzhou Immuno Biotech has developed a series of proteins and rapid test kits for the in vitro diagnostic industry in early stage. Gradually, IMMUNO was well known as a good R&D partner and good supplier of veterinary rapid test products. With great patience and continuous investment in design and development of IVD relative reagents and test kits, we got several encouraging achievements in the past year, especially in veterinary diagnostic field.

IMMUNO has participated in the fighting with the epidemic and made a contribution. With a deep reflection, IMMUNO has realized the possibility of potential pandemic of zoonosis in future between human beings and animals. Diseases between human and animal are important projects what we are familiar with and then we decided to persue the "One Health" philosophy from then on.

To achieve that goal, IMMUNO has decided to focus on the development of rapid testing tools for zoonosis diseases and formed a joint action within our group. Now, we have a scientific team to analyse and develop recombinant proteins and antibodies, a technical team to apply the proteins and antibodies to immunoassay format, and also a joint team to study the diseases themselves and their possible application scenarios.

Hangzhou Immuno Biotech Co., Ltd. will focus on the human medical diagnostic field and mainly cover the following directions: rapid tests for vector-borne diseases(VBDs), rapid tests for sexually transmitted diseases (STDs), rapid tests for respiratory system diseases and rapid tests for digestive system diseases. Besides, with strong R&D capability, we would pay more attention to the diagnosis of neglected tropical diseases (NTDs).

IMMUNO will continuously contribute to the development of diagnostic tools for the whole human society and nature world.

Production & Quality Control
Immunobio is providing all the products strictly following with quality management system. We are running the ISO9001 and ISO13485 quality control system to ensure the good quality of our products, and also the Intellectual Property Management system to protect the intellectual properties of both our clients and ourselves. Immunobio is also supplying uncut sheet format semi-product to our global partners. Immunobio is also providing rapid tests and OEM/private label services to our customers from every corner of the world.